"A First-in-human Study of HyperQureTM, Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension"

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 14, 2023

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2026

Conditions
Resistant Hypertension
Interventions
DEVICE

HyperQure Renal Denervation System

"The HyperQure RDN System consists of a generator that generates RF energy and a Laparoscopic Instrument that delivers the RF energy generated by the generator to the treatment area. Through a laparoscopic approach, the renal artery is accessed through the retroperitoneum, which is the closest path to the renal artery. After wrapping 360 degrees of renal artery, RDN is performed as per the preset parameters of 50 degrees and 70 seconds.~The target blood vessel is planned by CTA before the procedure, and the proximal and distal areas of the right and left main renal artery are treated once at a distance of at least 3 mm respectively, and RDN is also performed on the branch or accessory vessel confirmed to be suitable for the procedure by CTA."

Trial Locations (5)

Unknown

RECRUITING

Chonnam National University Hospital Hwasun Hospital, Jeonam

RECRUITING

Hanyang University Seoul Hospital, Seoul

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

RECRUITING

Yonsei University Health System, Severance Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DeepQure Inc.

INDUSTRY